Back to Search Start Over

Recreational Physical Activity and Outcomes After Breast Cancer in Women at High Familial Risk

Authors :
Kehm, RD
MacInnis, RJ
John, EM
Liao, Y
Kurian, AW
Genkinger, JM
Knight, JA
Colonna, S
Chung, WK
Milne, R
Zeinomar, N
Dite, GS
Southey, MC
Giles, GG
Mclachlan, S-A
Whitaker, KD
Friedlander, ML
Weideman, PC
Glendon, G
Nesci, S
Investigators, K
Phillips, K-A
Andrulis, IL
Buys, SS
Daly, MB
Hopper, JL
Terry, MB
Kehm, RD
MacInnis, RJ
John, EM
Liao, Y
Kurian, AW
Genkinger, JM
Knight, JA
Colonna, S
Chung, WK
Milne, R
Zeinomar, N
Dite, GS
Southey, MC
Giles, GG
Mclachlan, S-A
Whitaker, KD
Friedlander, ML
Weideman, PC
Glendon, G
Nesci, S
Investigators, K
Phillips, K-A
Andrulis, IL
Buys, SS
Daly, MB
Hopper, JL
Terry, MB
Publication Year :
2021

Abstract

BACKGROUND: Recreational physical activity (RPA) is associated with improved survival after breast cancer (BC) in average-risk women, but evidence is limited for women who are at increased familial risk because of a BC family history or BRCA1 and BRCA2 pathogenic variants (BRCA1/2 PVs). METHODS: We estimated associations of RPA (self-reported average hours per week within 3 years of BC diagnosis) with all-cause mortality and second BC events (recurrence or new primary) after first invasive BC in women in the Prospective Family Study Cohort (n = 4610, diagnosed 1993-2011, aged 22-79 years at diagnosis). We fitted Cox proportional hazards regression models adjusted for age at diagnosis, demographics, and lifestyle factors. We tested for multiplicative interactions (Wald test statistic for cross-product terms) and additive interactions (relative excess risk due to interaction) by age at diagnosis, body mass index, estrogen receptor status, stage at diagnosis, BRCA1/2 PVs, and familial risk score estimated from multigenerational pedigree data. Statistical tests were 2-sided. RESULTS: We observed 1212 deaths and 473 second BC events over a median follow-up from study enrollment of 11.0 and 10.5 years, respectively. After adjusting for covariates, RPA (any vs none) was associated with lower all-cause mortality of 16.1% (95% confidence interval [CI] = 2.4% to 27.9%) overall, 11.8% (95% CI = -3.6% to 24.9%) in women without BRCA1/2 PVs, and 47.5% (95% CI = 17.4% to 66.6%) in women with BRCA1/2 PVs (RPA*BRCA1/2 multiplicative interaction P = .005; relative excess risk due to interaction = 0.87, 95% CI = 0.01 to 1.74). RPA was not associated with risk of second BC events. CONCLUSION: Findings support that RPA is associated with lower all-cause mortality in women with BC, particularly in women with BRCA1/2 PVs.

Details

Database :
OAIster
Publication Type :
Electronic Resource
Accession number :
edsoai.on1340016667
Document Type :
Electronic Resource